Published June 22, 2018
| Version v1
Preprint
Open
Purification of ACVR1 alone and TGFBR1 (ALK5) complexed with FKBP12
Description
Purifications of ALK2 and ALK5 (the latter in complex with FKBP12) and crystal hits
Notes
The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA Darmstadt Germany, MSD, Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome [106169/ZZ14/Z].
Files
Files
(3.4 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:c0f9802defecee4dc68a12f63e2d2110
|
970.9 kB | Download |
|
md5:0740707a355d8e535a692346e4a3c9e2
|
1.5 MB | Download |
|
md5:bd9dd00765b955be81a4ede2ab9c25ef
|
854.5 kB | Download |